270 related articles for article (PubMed ID: 32683496)
21. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
22. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions.
Gonzalez-Gay MA
Semin Arthritis Rheum; 2004 Apr; 33(5):289-93. PubMed ID: 15079759
[TBL] [Abstract][Full Text] [Related]
23. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
[TBL] [Abstract][Full Text] [Related]
24. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
Reitsema RD; Hesselink BC; Abdulahad WH; van der Geest KSM; Brouwer E; Heeringa P; van Sleen Y
Front Immunol; 2023; 14():1201575. PubMed ID: 37600779
[TBL] [Abstract][Full Text] [Related]
25. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
Singh JA; Cleveland JD
Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
[TBL] [Abstract][Full Text] [Related]
26. Contemporary prevalence estimates for giant cell arteritis and polymyalgia rheumatica, 2015.
Crowson CS; Matteson EL
Semin Arthritis Rheum; 2017 Oct; 47(2):253-256. PubMed ID: 28551169
[TBL] [Abstract][Full Text] [Related]
27. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
28. Are polymyalgia rheumatica and giant cell arteritis the same disease?
Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
[TBL] [Abstract][Full Text] [Related]
29. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
[TBL] [Abstract][Full Text] [Related]
31. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
[TBL] [Abstract][Full Text] [Related]
32. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
33. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
[TBL] [Abstract][Full Text] [Related]
34. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden.
Uddhammar A; Eriksson AL; Nyström L; Stenling R; Rantapää-Dahlqvist S
J Rheumatol; 2002 Apr; 29(4):737-42. PubMed ID: 11950015
[TBL] [Abstract][Full Text] [Related]
35. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
36. High incidence of polymyalgia rheumatica and giant cell arteritis in a Swedish community.
Noltorp S; Svensson B
Clin Exp Rheumatol; 1991; 9(4):351-5. PubMed ID: 1934682
[TBL] [Abstract][Full Text] [Related]
37. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
[TBL] [Abstract][Full Text] [Related]
38. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
Gonzalez-Gay MA; Hajeer AH; Dababneh A; Garcia-Porrua C; Amoli MM; Llorca J; Ollier WE
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S18-20. PubMed ID: 15675129
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cardiovascular events in polymyalgia rheumatica and giant cell arteritis amongst an Asian population: Propensity score matched cohort study.
Kobayashi D; Suyama Y; Osugi Y; Arioka H; Takahashi O; Kuriyama N
Int J Rheum Dis; 2018 Jun; 21(6):1314-1321. PubMed ID: 29879315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
